Views: 466 Author: Site Editor Publish Time: 2026-06-02 Origin: Site
When we boarded the flight from China to Barcelona on May 4th, we carried more than product samples and company brochures. We brought years of expertise in pharmaceutical-grade bioactive ingredients—sodium hyaluronate, chondroitin sulfate, and glucosamine—and a clear mission: to deepen our understanding of what European supplement brands, formulators, and ingredient buyers are actively seeking—and to show them exactly why Chinese manufacturers have become indispensable to this market.
Vitafoods Europe 2026 returned to Barcelona's Fira Gran Via convention centre for its second consecutive year following the show's historic relocation from Geneva. This year's edition drew 26,767 attendees from 135 countries, with over 1,550 exhibitors filling the massive halls. The numbers tell part of the story; the conversations tell the rest.
At our booth, we showcased Runxin Biotech's comprehensive portfolio of joint health and beauty-from-within ingredients:
Sodium Hyaluronate continues its dominance in both oral supplements and topical applications. European consumers have grown sophisticated about ingredient sourcing, asking pointed questions about molecular weight specifications, fermentation methods, and documented purity levels. The days of "HA is HA" thinking are over; quality differentiation now drives purchasing decisions.
Chondroitin Sulfate remains a cornerstone of joint health formulations, particularly for osteoarthritis management. European buyers showed increasing interest in chondroitin sulfate sourced from biofermentation pathways, avoiding animal-derived alternatives. Questions about molecular weight distribution, sulfur content, and purity dominated our technical discussions.
Glucosamine—whether as glucosamine sulfate, glucosamine hydrochloride, or N-acetyl-glucosamine—continues its steady presence in the joint health market. The combination of glucosamine with chondroitin sulfate and hyaluronic acid in "triple-action" formulations represents one of the fastest-growing segments we observed at the show.
Walking the show floor, several clear patterns emerged that will shape how we position our ingredient offerings going forward.
Clean label pressure is intensifying. Multiple conversations confirmed what trade publications have been reporting: European buyers increasingly demand "free-from" credentials, non-GMO verification, sustainable sourcing documentation, and traceable supply chains. For us, this means our pharmaceutical-grade ingredients with full traceability documentation fit perfectly into this premium positioning. Customers aren't just buying raw materials—they're buying compliance confidence.
Regulatory complexity creates both friction and opportunity. Several visitors mentioned struggling with EU Novel Food regulations and the 6-8 month preparation timeline required for certain ingredient certifications. Chinese suppliers who can provide pre-assembled regulatory packages gain significant competitive advantage. This is where technical documentation and proactive compliance support directly translate to business development.
Combination formulations are trending. The "beauty-from-within" and "joint health from within" categories increasingly feature multi-ingredient combinations. Formulators seek suppliers who can provide consistent quality across multiple ingredients—precisely our positioning as a three-product portfolio supplier.
China supplies approximately 80-85% of global hyaluronic acid and a significant share of chondroitin sulfate produced via biofermentation. Yet the narrative has shifted. Gone are the simple days of competing solely on price. Today's European buyers want:
· Consistent molecular weight distribution (our standard: 600,000–1,200,000 Da for cosmetic grade HA, with tighter specifications available)
· Batch-to-batch consistency backed by analytical data
· Responsive technical support that understands both Western regulatory frameworks and Asian manufacturing advantages
· Supply chain resilience that demonstrated itself during recent global disruptions
At our booth, we had substantive discussions with visitors from Spain, Germany, France, the Netherlands, and Poland. What struck us most was the quality of questions: these weren't casual inquiries but detailed technical discussions about endotoxin levels, heavy metal specifications, and stability data. European nutraceutical buyers have become sophisticated ingredient purchasers, and they expect suppliers who can match their expertise.
Spain itself represents an increasingly important nutraceutical market. With a market size of €32 billion and an 8.8% compound annual growth rate, Spain ranks as southern Europe's fastest-growing health ingredients market. The country's strategic position provides distribution access across eight neighboring markets including Portugal, France, and Italy.
The show's location reinforced this gateway positioning. Multiple distributors we spoke with expressed interest in establishing long-term supply relationships that could serve their broader European customer bases. For ingredient manufacturers, building these regional distribution partnerships offers scalability that direct-to-brand sales cannot match.
Vitafoods Europe has always served as a barometer for ingredient innovation trends. This year's show highlighted several application areas where our three core ingredients could play expanded roles:
GLP-1 companion nutrition dominated conference programming, with dedicated sessions exploring how functional ingredients can support users of weight management medications. Side effects like joint discomfort and skin changes create natural opportunities for our combined ingredient portfolio—glucosamine and hyaluronic acid for joint support, hyaluronic acid for skin hydration. These conversations represent opportunities we intend to develop further.
Women's health continued its trajectory from niche to mainstream. Ingredients addressing menstrual cycle support, menopause symptoms, and fertility wellness filled multiple exhibition zones. Glucosamine and chondroitin sulfate for bone and joint health during hormonal transitions, combined with hyaluronic acid for skin integrity, represent natural extensions of our existing product positioning.
Longevity and healthy aging has evolved beyond anti-aging messaging into holistic wellness conversations. European consumers increasingly seek ingredients that support cellular health, joint mobility, and skin integrity across the lifespan. Our three core ingredients—each with documented benefits in these areas—position us well within this broader longevity framework.
Three days at Vitafoods Europe confirmed what we've believed for years: the European nutraceutical market rewards quality, consistency, and technical partnership. Price competition exists, certainly, but the buyers who return year after year are those who found suppliers who could grow with them.
Our conversations in Barcelona generated promising leads across multiple applications—from joint health supplements targeting the aging European population to premium beauty-from-within products demanding pharmaceutical-grade ingredient specifications.
We'll be following up with every contact who requested our technical documentation packages, certificate of analysis samples, and pricing discussions. If you visited our booth and are reading this, thank you for taking the time to discuss your ingredient needs. We look forward to continuing those conversations.
For those who missed us at the show, our team remains available for virtual consultations. We're particularly prepared to discuss:
· Sodium Hyaluronate: Customized molecular weight specifications, fermentation source verification, and stability documentation for cosmetic and pharmaceutical applications
· Chondroitin Sulfate: Biofermentation-derived alternatives to animal sources, molecular weight optimization, and purity profile customization
· Glucosamine: Multiple forms (sulfate, HCl, NAG) with specifications tailored to specific formulation requirements
· Combined "triple-action" formulations featuring all three ingredients
· EU regulatory compliance documentation and support
· Sample availability and technical data packages
· Flexible MOQ arrangements for emerging brands and established manufacturers alike
Barcelona proved once again that in-person connections remain irreplaceable in the ingredient business. The conversations started here—in exhibition halls, over coffee, during product demonstrations—lay groundwork for partnerships that will develop over months and years.
Runxin Biotech's participation in Vitafoods Europe 2026 reinforced our commitment to the European market. As Chinese manufacturers of hyaluronic acid, chondroitin sulfate, and glucosamine continue improving quality standards and regulatory sophistication, we believe our role in European nutraceutical supply chains will only grow more significant.
Thank you to everyone who visited our booth, shared insights about your markets, and took the time to discuss ingredient needs with us. The European nutraceutical industry continues evolving rapidly, and we're committed to evolving with it—delivering the quality, consistency, and technical partnership that your formulations deserve.
Until next year's show, we remain at your service.
Runxin Biotech specializes in pharmaceutical-grade sodium hyaluronate, chondroitin sulfate, and glucosamine for nutraceutical, cosmetic, and medical applications. Contact us to discuss your ingredient requirements or request technical documentation.
